Cargando…
PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429824/ http://dx.doi.org/10.1097/01.HS9.0000974980.19869.72 |
| _version_ | 1785090808008933376 |
|---|---|
| author | Hartford, Christopher Nguyen, Quang P. Sherman, Steven Pavani, Rodrigo Aurand, Lisa Rofail, Diana Kelly, Richard |
| author_facet | Hartford, Christopher Nguyen, Quang P. Sherman, Steven Pavani, Rodrigo Aurand, Lisa Rofail, Diana Kelly, Richard |
| author_sort | Hartford, Christopher |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429824 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104298242023-08-17 PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA Hartford, Christopher Nguyen, Quang P. Sherman, Steven Pavani, Rodrigo Aurand, Lisa Rofail, Diana Kelly, Richard Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429824/ http://dx.doi.org/10.1097/01.HS9.0000974980.19869.72 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Hartford, Christopher Nguyen, Quang P. Sherman, Steven Pavani, Rodrigo Aurand, Lisa Rofail, Diana Kelly, Richard PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title | PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title_full | PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title_fullStr | PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title_full_unstemmed | PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title_short | PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| title_sort | pb2044: final patient-reported outcomes from a phase 2, randomised trial evaluating the safety and efficacy of pozelimab and cemdisiran in patients with paroxysmal nocturnal haemoglobinuria |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429824/ http://dx.doi.org/10.1097/01.HS9.0000974980.19869.72 |
| work_keys_str_mv | AT hartfordchristopher pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT nguyenquangp pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT shermansteven pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT pavanirodrigo pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT aurandlisa pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT rofaildiana pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria AT kellyrichard pb2044finalpatientreportedoutcomesfromaphase2randomisedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhaemoglobinuria |